Beyin Haritası (Brain Mapping) KAYNAKLAR

1. Arikan MK.: Konsültasyon Liyezon Psikiyatrisi Nedir? Aile Hekimliği Dergisi, Kabul Tarihi Ocak 1998

2. Dietsch G.Fourier analyse von Elektroencephalogrammen des Menschen. Pflgers arch., 230 :106-12., I932

3. Bloomfield P.: Fourier Analysis of Time Series: An Introduction. Ed. by Peter Bloomfield, Published by John Wikey & Sons, p. I-8,I976

4. Berger H.Uber das Elekroenkephalogramm des Menschen. IV, Mitteilung.Arch Psychiatr Nervenkr; 97: 6-26,1932

5. Berger H.Uber das Elekroenkephalogramm des Menschen. IX. Mitteilugn .Arch Psychiatr Nervenkr: IO2; 538-57, I934.

6. Berger H.Uber das elekroenkephalogramm des Menschen IX. Mitteilugn.Arch Psychiatr Nervenkr; IO4; 678-89, I936.

7. Livanov MN. The analysis of bioelectric oscillations in the cortex of the rabbit. Nevro pat. Psihiat: 3: 98-115, 1934.

8. Grass MA., Gbbs FA., A Fourier transform of the EEG.J Neurophysiol: I: 521-6, 1938.

9. Knott JR., Gibbs FA., Henry CE., Fourier transform of the electroencephalogram du­ring sleep. J. Exp. Psychol: 31:465-77, 1942.

10. Walter W Grey.An improved low frequency analyzer. Electronic Eng.: 16:236-40, 1943.

11. Cuffin BN Effects of local variations in skull and scalp thickness on EEG's and MEG'S. IEEE Trans Biomed Eng, 40:1, 42-8, 1993

12. Itil T.M., Itil K.Z., Eralp E., Akman A.,Manco A..: "CEEG Dynamic Brain Mapping, A New Method To Evaluate Brain Function In Different Psychological And Drug Conditions". In AGARD Conference Preceding No.432 on "Electric And Magnetic Activity of The Central Nervous System: Research And Clinical Applications in Aerospace Medicine", Trondheim Norway Specialized Printing Services Limited, Essex, Great Britain, Feb, 1988.

13. Cohn R. A cycloscopic study of the human electroencephalogram. J. Gen.Physiol.: 25: 517- 22, 1942.

14. Cohn R. A simple method for cerebral toposcopy. Electroencephalogr Clin Neurophysiol: 2: 517-22,1950

15. Goldman S., Vivian WE., Chien CK., Bowes HN., Electronic mapping of the activity of the heat and brain. Science: 108:16:720-3, 1948.

16. Lilly JC. A 25 -channel potential field recorder. In: Second annual joint IRE-AIEE conference on electronic instrumentation in nucleonics and medicine. New York: IRE.1949.

17. Walter W Grey,Shipton HW.A new toposcopic display system. Electroencephalogr Clin Neurophysiol. 3: p.281-92, 1951.

18. Barlow JS. Brazier MAB Note on a 11correlator for electro encephalographic work, electroencephalogr Clin Neurophysiol: (6) 321-15, 1954.

19. Brazier MAB, Casby JU- Some applications of correlation analysis lo clinical problems in electroencephalography. Electroencephalogr Clin Neurophysiol, 8: 325-31, 1956

20. Delacour J.,Bassant EMH.,Onofrj M., Santucci V., Kleinlogel H.: Electrophysiological models for study of cognition enhancers. Pharmacopsychiatry, 23 Sppl.2:90-3, 1990.

21. Saltzberg B., Burch NR., McLennan MA., Corell EG., A new Trans Med Electron : 8:24-30,1957.

22. Dumermuth G., Fluhler H.Some modern aspects in numerical spectrum analysis of multichannel electroencephalograpic data. Med. Biol. Eng.: 5:319-31, 1967.

23. Kunkel H. Historical review of principles methods. In: Remond A. ed. EEG informatics. A didactic review of methods and applications of EEG data processing. Amsterdam: Elsevier / North Holland Biomedical Press.: 9-25,1977.

24. Dierks T; Becker T; Maurer K Brain electrical activity in depression described by equivalent dipoles. J Affect Disord, 28:2, 95-104, 1993.

25. Itil T.M.. Mucci A., Eralp E.,: "Dynamic Brain Mapping Methodology And Application" Int. J. Psychophysiology. 10: 281-291, 1991.

26. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, 10(11), p.1611-6, 1990.

27. Human Drugs, Federal Register,Vol 40,No 120,26157-26171, 1975.

28. Craig JC,Gruenke LD: A contribution to psychoactive drug measurement techniques. In Gottschalk LA, Merlis S (eds): Pharmacokinetcs of Psychoactive Drugs: Blood levels and Clinical Response. New York, Spectrum Publications, l976.

29. Bioavailability and Bioequivalence Requirements. Federal Register, Vol 42, No 5, 1639, 1977.

30. Final task force report on bioavailability and bioequivalence of psychotropic drugs. Psychopharmacol Bull 16 (Suppl 3) 9-12,1980.

31. Itil TM.: Quantitate pharmaco-electroencephalography in assessing new antianxiety agents, in Vinar O., Votava 2., and Bradley PB:, editors: Advances in neuro-psychopharmacology. North Holland Publishing Co., Amsterdam, p. 199-209, 1971.

32. Itil TM, Gannon P.,Cora R., Polvan N.,Akpinar S., Elveris F., and Eskazan E.: SCH-12041, a new anti;anxiety agent (quantitave pharmacoencephalography and clinical trials), Physiscians' Drug Manual (PDM), 3(3-4): 26-35,1971.

33. Itil TM., Guven F., Cora R, Hsu W., Polvan N., Ucok A., Sanseigne A., and Ulett GA.: Quantitate pharmaco-electroencephalography using frequency analyzer and digital computer methods in early drug evaluations,in Smith WL.,editor: Drugs, Development,and Brain Functions, Chlarles C.Thomas, Springfield,III,p.145-166,1971.

34. Itil TM.: Quantitate pharmaco-encephalography in the discovery of a new group of psychotropic drugs, Diseases of the Nervous System,33,(8): 557-9,1972.

35. Itil TM.,Saletu B., Gannon P., Arat M.,and Hsu W.: Clinical and EEG investigations with CI-579 and CI-600 (Quantitative pharmaco-electroencephalograhpy and sleep prints') Physicians' Drug Manual,4(3-4): 2-10,1972.

36. Itil T.M., Quantitate Pharmaco-Electroencephalography'. In Itil T.M. (Ed), Psychotropic Drugs and th Human EEG. Mod.43-75,1974.

37. Bente D., Itil TM: Zur Wirkund des Phenothiazin korpers Megaphen aud das
menschliche Hirnstromblid, Arnz. Forsch., 4:418-423,1954

38. Itil TM.: Elektroencephalographische studien bei psychosen und psychotropen Medikamenten,Ahmet Sait Matbaasi, Istanbul,1964.

39. Fink M.: Quantitative electroencephalography and human psychopharmacoolgy: frequency spectra and drug action, Med. Exp., 5:364- 369.1961.

40. Fink M.,: Quantitate electroencephalography in human psychopharmacoolgy. II. Drug patterns, in Glaser GH: EEG and behavior,Basic Books,New York,1963.

41. Fink M.: Quantitative EEG and human psychopharmacology. III. Changes on acute and chronic administration of chorpromazine, imipramine.and placebo (saline),in Wilson WP: Applications of electroencephalography in psychiatry , Duke Univ<. Press. Durhan., N.C., I965.

42. Fink M., and Itil TM.: EEG analysis by digital computer.

II: Relation ofpenthotal- induced changes to resting patterns, Electroenceph. Clin.Neurophysiol, 18: 520-521,1965.

43. Fink M.: The human electroencephalogram : index of clinical activity of new psychoacti­ve agents. Mod. Probl Pharmacopsychiat., Vol. 2, Basel - Karger, Basel - New York, 1969.

44. Fink M: Strategies of new psyschotropic drug development. Presented at the scientific meeting on the occasion of the 50 th anniversary of Organon, Amsterdam, Oct.27,1971.

45. Itil TM.: elektroencephalographische befunde zur klassifikation neuro und thymoleptischer Medikamente,Med. Exp. (Basel), 5:347-363,1961.

46. Itii TM: Electroencephalography and pharmacopsychiatry, in Freyhan FA., Petrilowitsch N.,and Pichot P.,editors:Clinical Psychopharmacology,Modern problems of pharmacopsychiatry, Vol. 1., Karger, Basel New York, p.63-194,1968.

47. Itil TM., Cabana B., Purich E.,Songar A., eralp E.: Establishing bioavailability following single doses of two generic products of diazepam relative to Valium usimgn both stan­dard plasma hlevels and computer analyzed electroencephalography measurements. Integrat Psychiat 3:25-41,1985.

48. Shapiro D., Hsu W., Itil TM.: Period analysis of the EEG on the PDP-12, in Wulfsohn NL.,and Sances A Jr., editors: The nervous system and electric currents, Vol.2., Plenum Press, New York, p.59, 1971.

49. Loomis AL., Harvey EN., Hobart GA.: Cerebral states during sleep as studied by human brain potentials, J. Exp Psychol, 21:127-144,1937

50. Loomis AL., Harvey EN., Hobart GA.: Distribution of disturbance patterns in the human electroencephalogram with special reference to sleep. J. Neurophysiol. 1: 413-43,1938

51. Blake H., Gerard RW.: Brain potentials during sleep. Am. J. Physiol. 119: 273-274,1937

52. Aserinsky E, Kleitman N: Regular occuring periods of eye motility and concomitant phenomena during sleep. Science 118:273-274,1953

53. Dement W., Kleitman N.: Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroencephalogr. Clin. Neurophysiol. 9:673-690, 1957

54. Terzano MG., Parrino L.: Functional relationship between micro- and macrostructure of sleep. In. Phasic events and dynamic organization of sleep. Eds. MG Terzano, P. Halasz, AC Declerck, pp.101-119, New York Raven Press, 1991

55. Arıkan MK., Cetin G.: : Uyku Bozukluklan, yeraldığı kitap: Psikiyatri, eds. İlkay E., i.U. Cerrahpasa Tip Fakultesi Yayinlan, 1998

56. Sutton S., Braren M., Zubin J., John ER.: Evoked correlates of stimulus uncertainty. Science, 50,1187-1188,1965.

57. Arıkan MK.: Psikiyatrik Elektrofizyoloji. yeraldığı kitap: Psikiyatri, eds. ilkay E., i.U. Cerrahpasa Tip Fakültesi Yayınları, 1998.

58. Malaspina D; Devanand DP; Krueger RB; Prudic J; Sackeim HA The significance of clinical EEG abnormalities in depressed patients treated with ECT. Convuls Ther, 10:4, 259-66,1994

59. Mas F; Prichep LS; Alper K Treatment resistant depression in a case of minor head injury: an electrophysiological hypothesis. Clin Electroencephalogr, 24:3,118-22,1993

60. Arıkan MK.: Electrophysiological Aspects of Depression, Thesis, New York, 1992

61. Knott VJ; Telner J1; Lapierre YD; Browne M; Horn ER Quantitative EEG in the prediction of antidepressant response to imipramine. J Affect Disord, 29,39:3,175-84, 1996

62. Itil TM., Arikan MK., Itil K., Le Bars P., Eralp E.;Clinical CEEG/DBM Findings With A New Antidepressant: Dothiepin; Integrative Psychiatry, 8(3), 241 - 51,1992

63. Luthringer R; Minot R; Toussaint M; Calvi-Gries F; Schaltenbrand N; Macher JP Allnight EEG spectral analysis as a tool for the prediction of clinical response to antidepressant treatment. Biol Psychiatry, 15, 38:2, 98-104,1995

64. Paige SR; Fitzpatrick DF; Kline JP; Balogh SE; Hendricks SE Event-related potential amplitude/intensity slopes predict response to antidepressants. Neuropsychobiology, 30:4, 197-201,1994

65. Mendlewicz J; Kempenaers C; de Maertelaer V Sleep EEG and amitryptiline treatment in depressed inpatients. Biol Psychiatry, 1, 30:7, 691-702,1991

66. Paige SR; Hendricks SE; Fitzpatrick DF; Balogh S; Burke WJ Ampltude/intensity functions of auditory event-related potentials predict responsiveness to bupropion in major depressive disorder. Psychopharmacol Bull, 31:2, 243-8,1995

67. Reynolds CF 3d; Hoch CC; Buysse DJ; George CJ; Houck PR; Mazumdar S; Miller M; Pollock BG; Rifai H; Frank E; et al Sleep in late-life recurrent depression. Changes during early continuation therapy with nortriptyline. Neuropsychopharmacology, 5:2, 85-96, 1991

68. Leentjens AF; van den Broek WW; Kusuma A; Bruijn JA Facilitation of ECT by intravenous administration of theophylline. Convuls Ther, 12:4, 232-7,1996

69. Trzepacz PT; Weniger FC; Greenhouse J Etomidate anesthesia increases seizure duration during ECT. A retrospective study. Gen Hosp Psychiatry, 15:2,115-20,1993

70. Kirkby KC; Beckett WG; Matters RM; King TE Comparison of propotol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Aust N Z J Psychiatry, 29:2, 299-303, 1995

71. Coffey CE; Lucke J; Weiner RD; Krystal AD; Aque M Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT. Biol Psychiatry, 1, 37:11, 777- 88, 1995

72. Mitchell P; Torda T; Hickie I; Burke C Propofol as an anaesthetic agent for ECT: effect on outcome and length of course. Aust N Z J Psychiatry, 25:2, 255-61,1991

73. Martensson B; Bartfai A; Hallen B; Hellstrom C; Junthe T; Olander M A comparison of propofol and methohexital as anesthetic agents for ECT: effects on seizure duration, therapeutic outcome, and memory. Biol Psychiatry, 35:3,179-89,1994

74. Suppes T; Webb A; Carmody T; Gordon E; Gutierrez-Esteinou R;Hudson Jl; Pope HG Jr Is postictal electrical silence a predictor of response to electroconvulsive therapy? J Affect Disord, 4, 41:1, 55-8 ,1996

75. Buysse DJ; Kupfer DJ; Frank E; Monk TH; Ritenour A; Ehlers CL Electroencephalographic sleep studies in depressed outpatients treated with interpersonal psychotherapy. I. Baseline studies in responders and nonresponders. Psychiatry Res, 42:1,13-26,1992

76. Thase ME; Buysse DJ; Frank E; Cherry CR; Cornes CL; Mallinger AG; Kupfer DJ Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal EEG sleeps profiles. Am J Psychiatry, 154:4, 502-9,1997

77. Thase ME; Simons AD; Reynolds CF 3rd Abnormal electro encephalographic sleep profiles in major depression: association with response to cognitive behavior therapy. Arch Gen Psychiatry, 53:2, 99-108,1996

78. Riemann D; Hohagen F; Fritsch-Montero R; Krieger S; Gann H; Dressing H; Muller W; Berger M Cholinergic and noradrenergic neurotransmission: impact on REM sleep regulation in healthy subjects and depressed patients. Acta Psychiatr Belg, 92:3,151-71,1992

79. Riemann D; Hohagen F; Fleckenstein P; Schredl M; Berger M The cholinergic REM induction test with RS 86 after scopolamine pretreatment in healthy subjects. Psychiatry Res, 38:3, 247-60,1991

80. Jones BE Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience, 1991, 40:3, 637-56

81. Kok A REM sleep pathways and anticholinesterase intoxication: a mechanism for nerve agent-induced, central respiratory failure. Med Hypotheses, 41:2,141-9,1993

82. Myers JE; Buysse DJ; Thase ME; Perel J; Miewald JM; Cooper TB; Kupfer DJ; Mann JJ The effects of fenfluramine on sleep and prolactin in depressed inpatients: a comparison of potential indices of brain serotonergic responsivity. Biol Psychiatry, 34:11,753-8,1993.

83. Valentino RJ; Curtis AL Pharmacology of locus coeruleus spontaneous and sensoryevoked activity. Prog Brain Res,88:, 249-56,1991

84. Holsboer F; Grasser A; Friess E; Wiedemann K Steroid effects on central neurons and implications for psychiatric and neurological disorders. Ann N Y Acad Sci, 746:, 345-59; discussion 359-61,1994

85. Schenck CH; Mahowald MW; Kim SW; O'Connor KA;Hurwitz TD Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with
fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep, 15:3, 226-35, 1992

86. van Bemmel AL The link between sleep and depression: the effects of antidepressants on EEG sleep. J Psychosom Res, 42:6, 555-64, 1997

87. Seifritz E; Hemmeter U; Trachsel L; Lauer CJ; Hatzinger M; Emrich HM; Holsboer F; Holsboer-Trachsler Effects of flumazenil on recovery sleep and hormonal secretion after sleep deprivation in male controls. Psychopharmacology (Berl), 120:4, 449-56, 1995

88. Borbely AA; Achermann P Ultradian dynamics of sleep after a single dose of benzodiazepine hypnotics. Eur J Pharmacol, 195:1,11-8,1991

89. Seifritz E; Muller MJ; Schonenberger GA; Trachsel L; Hemmeter U; Hatzinger M; Ernst A; Moore P; Holsboer-Trachsler E Human plasma DSIP decreases at the initiation of sleep at different circadian times. Peptides, 16:8,1475-81,1995

90. Gangadhar BN; Ancy J; Janakiramaiah N; Umapathy C P300 amplitude in non-bipolar, melancholic depression. J Affect Disord, 28:1, 57-60,1993

91. Ogura C; Nageishi Y; Omura F; Fukao K; Ohta H; Kishimoto A; Matsubayashi M N200 component of event-related potentials in depression. Biol Psychiatry, 33:10, 720-6, 1993

92. Steiger A; Holsboer F; Benkert O Studies of nocturnal penile tumescence and sleep electroencephalogram in patients with major depression and in normal controls. Acta Psychiatr Scand, 87:5, 358-63, 1993

93. Steiger A; von Bardeleben U; Guldner J; Lauer C; Rothe B;Holsboer F The sleep EEG and nocturnal hormonal secretion studies on changes during the course of depression and on effects of CNS-active drugs. Prog Neuropsychopharmacol Biol Psychiatry, 17:1,125-37, 1993

94. Haag C; Kathmann N; Hock C; Gunther W; Voderholzer U; Laakmann G Lateralization of the Bereitschaftspotential to the left hemisphere in patients with major depression. Biol Psychiatry,36:7,453-7,1994

95. Szegedi A; Wetzel H; Leal M; Hartter S; Hiemke C Combinati on treatment with clomipramine and fluvoxamine: drug monitoring,safety, and tolerability data. J Clin Psychiatry, 57:6, 257-64,1996.

96. Durkheim E.: intihar. Toplumbilimsel inceleme. Cev. Ozankaya 6., Türk Tarih Kurumu Basımevi, Ankara, 1986.

97. Hansenne M; Pitchot W; Gonzalez Moreno A; Gonzalez Torrecilas J; Mirel J; Ansseau M Psychophysiological correlates of suicidal behavior in depression. A preliminary study. Neuropsychobiology, 30:1,1-3,1994

98. Ashton CH; Marshall EF; Hassanyeh F; Marsh VR; Wright-Honari S Biological correla­tes of deliberate self-harm behaviour: a study of electroencephalographic, biochemi­cal and psychological variables in parasuicide. Acta Psychiatr Scand, 90:5, 316-23, 1994

99. Graae F; Tenke C; Bruder G; Rotheram MJ; Piacentini J; Castro-Bianco D; Leite P; Towey J Abnormality of EEG alpha asymmetry in female adolescent suicide attempters. Biol Psychiatry, 40:8, 706-13,1996

100. Sabo E; Reynolds CF 3d; Kupfer DJ; Berman SR Sleep, depression, and suicide. Psychiatry Res,36:3, 265-77,1991

101. Dew MA; Reynolds CF 3rd; Buysse DJ; Houck PR; Hoch CC; Monk TH; Kupfer DJ Electroencephalographic sleep profiles during depression. Effects of episode duration and other clinical and psychosocial factors in older adults. Arch Gen Psychiatry, 53:2,148-56,1996

102. Blackwood D; St. Clair D; Muir W DNA markers and biological vulnerability markers in families multiply affected with schizophrenia. Eur Arch Psychiatry Clin Neurosci, 240:3,191-6,1991

103.Giles DE; Jarrett RB; Rush AJ; Biggs MM; Roffwarg HP Prospective assessment of eiectroencephalographic sleep in remitted major depression. Psychiatry Res, 46:3,269-84,1993

104. Lauer CJ;SchreiberW; Holsboer F;Krieg JC In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatry, 52:2,145-53, 1995

105. Perlis ML; Giles DE; Fleming GM; Drummond SP; James SP Sustained facial muscle activity during REM sleep and its correlation with depression. J Affect Disord, 35:4, 163-71, 1995

106. Dawson G; Klinger LG; Panagiotides H; Hill D; Spieker S Frontal lobe activity and affective behavior of infants of mothers with depressive symptoms. Child Dev, 63:3, 725-37, 1992

107.Dawson G; Frey K; Panagiotides H; Osterling J; Hessl D Infants of depressed mothers exhibit atypical frontal brain activity: a replication and extension of previous findings. J Child Psychol Psychiatry,38:2,179-86,1997.

108. Buysse DJ; Reynolds CF 3rd; Hoch CC; Houck PR; Kupfer DJ; Mazumdar S; Frank E Longitudinal effects of nortriptyline on EEG sleep and the likelihood of recurrence in elderly depressed patients. Neuropsychopharmacology, 14:4, 243-52,1996

109. Reynolds CF 3rd; Frank E; Houck PR; Mazumdar S; Dew MA; Cornes C; Buysse DJ; Begley A; Kupfer DJ Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication? Am J Psychiatry, 154:7, 958-62,1997

110. Thase ME; Kupfer DJ; Buysse DJ; Frank E; Simons AD; McEachran AB; Rashid KF; Grochocinski VJ Electroencep-halographic sleep profiles in single-episode and recurrent unipolar forms of major depression: I. Comparison during acute depressive states. Biol Psychiatry, 38:8, 506-15,1995

111. Prichep LS; John ER QEEG profiles of psychiatric disorders. Brain Topogr, 4:4, 249-57, 1992

112. Nuwer M Assessment of digital EEG, quantitative EEG, and EEG brain mapping: report of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology, 49:1, 277-92,1997

113. Anonymous Quantitative electroencephalography: a report on the present state of computerized EEG techniques. American Psychiatric Association Task Force on Quantitative Electrophysiological Assessment. Am J Psychiatry, 148:7, 961-4,1991

114. Fink M., Itil TM.: EEG and Human Psychopharmacology : Clinical Antidepressants, in Efron DH., Cole JO., Levine J., Witterborn RO (eds): Psychopharmacology: A Review of Progres, 1957-1967, Washington DC, US Government Printing Office, p. 671-682,1968

115. Borenstein D., Cujo P., Chiua M.: A propos de la Classification des Sibstances Psychotropes selon leurs efferts sur I Elecroentcephalogramme, Ann.Med. psychol., 2: 429-452,1965

116. Guillerm H., Davost PH., Grandmontagne 0.. Prudhomme B.: Efficacite du niaiamide dans les etats depressifs, Ann med. psychol., IIS (l):972-978,1960.

117. Raine AC, Thomas SR: Severe brain syndrome following phenelzine overdosage, Am.J. Psychiatry,119: 373-382,1962.

118. Fink M., Itil TM., Zaks A., Freedman AM.: EEG patterns of cyclazocine,a narcotic antagonist, in Karczmar A., and Koella W. (eds) Neurophysioolgical and behavioral aspects of psychotoropic drugs, Charles C.Thomas, Springfield, III., p.62-71,1969.

119. Funderbunk WH., Finger KF., Drakontides AB., Scheider JA.: EEG and biochemical findings with MAO inhibitors, Ann. N.Y. Acad Sci., 96: 289-302,1962.

120. Gayral L, Turnin J.: Notes sur liactivite de quelques hydrazides inhibitrices de la monoamine-oxydase sur I'electroencephalogrammes de l'homme,Rev. neurol.,

121. Itil TM., Shapiro D.and Fink M.: Differentiation of psychotropic durgs by quantitative EEG analysis. Agressologie, 9(2):267-280, l968.

122. Itil TM.,Shapiro DM., Fink M., Kiremitci N.,Hickman C: Quan-titative EEG studies of chlordiazepoxide,chlorpromazine, and imipramine in volunteer and schizophrenic subjects,in Evans WO,Kline NS (eds): The psychopharmacology of the normal human,Charles C.Thomas Springfield,II., p.219-237,1969.

123. Fink M.: EEG profiles and bioavailability measures of psychoactive drugs, in Itil TM editor: Psychotropic drugs and the human EEG. Karger,Basel - New York, p.76-98,1974.

124. Staner L; Kerkhofs M; Detroux D; Leyman S; Linkowski P; Mendlewicz J Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep, 18:6, 470-7,1995

125. Kupfer DJ; Pollock BG; Perel JM; Jarrett DB; McEachran AB; Miewald JM Immediate effects of intravenous clomipramine on sleep and sleep-related secretion in depressed patients. Psychiatry Res, 36:3, 279-89,1991

126. Teicher MH; Glod CA; Cole JO Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf, 8:3,186-212,1993

127. Kupfer DJ; Perel JM; Pollock BG; Nathan RS; Grochocinski VJ; Wilson MJ; McEachran AB Fluvoxamine versus desipramine: comparative polysomnographic effects. Biol Psychiatry, 1, 29:1, 23-40, 1991

128. Sonntag A; Rothe B; Guldner J; Yassouridis A; Holsboer F; Steiger ATrimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression, 4:1,1-13,1996

129. Galderisi S; Mucci A; Bucci P; Mignone ML; Maj M Influence of moclobemide on cognitive functions of nine depressed patients: pilot trial with neurophysiological and neuropsyc-hological indices. Neuropsychobiology, 33:1, 48-54,1996

130. Minot R; Luthringer R; Macher JP Effect of moclobemide on the psychophysiology of sleep/wake cycles: a neuroelect-rophysiological study of depressed patients administered with moclobemide. Int Clin Psychopharmacol, 7:3-4,181-9,193.

131. Itil TM.,Akpinar S.: Lithium effect on human electroencephalogram, Clinical Electroencephalography, 2(2) :89-102,1971.

132.Saletu B. Grunberger J.: Classification and Determination of Cerebral Bioavailability of Fluoxetine: Pharmacokinetic, Pharmaco-EEG, and Psychometric Analyses. J. Clin Psychiatry. 46: 45-52, 1985.

133. Nofzinger EA; Reynolds CF 3rd; Thase ME; Frank E;Jennings JR; Fasiczka AL; Sullivan LR; Kupfer DJ REM sleep enhancement by bupropion in depressed men. Am J Psychiatry, 152:2, 274-6,1995

134. Armitage R; Trivedi M; Rush AJ Fluoxetine and oculomotor activity during sleep in depressed patients. Neuropsychopharmacology, 12:2,159-65,1995

135. Roschke J; Kogel P; Schlosser R; Wagner P; Mann K; Rossbach W; Benkert O Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects. Psychopharmacology (Berl), 132:1, 44-9,1997

136.Armitage R; Rush AJ; Trivedi M; Cain J; Roffwarg HP The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology, 10:2,123-7,1994

137.Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Psychopharmacol Bull, 32:4, 637-46,1996.

138.Saletu B; Grunberger J; Anderer P; Linzmayer L; Zyhlarz G Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and inhibiting fluvoxamine utilizing EEG mapping and psychometry. J Neural Transm, 103:1-2,191-216,1996

139. van Bemmel AL; Havermans RG; van Diest R Effects of trazodone on EEG sleep and clinical state in major depression. Psychopharmacology {Berl), 107:4, 569-74,1992

140. Buysse DJ; Frank E; Lowe KK; Cherry CR; Kupfer DJ Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biol Psychiatry,41:4,406-18,1997

141. Thase ME; Reynolds CF 3rd; Frank E; Jennings JR; Nofzinger E; Fasiczka AL; Garamoni G; Kupfer DJ Polysomnographic studies of unmedicated depressed men before and after cognitive behavioral therapy. Am J Psychiatry, 151:11,1615-22,1994

142. Yang X; Liu X; Luo H; Jia Y Clinical observation on needling extrachannel points in treating mental depression. J Tradit Chin Med, 14:1,14-8,1994

143.Field T; Ironson G; Scafidi F; Nawrocki T; Goncalves A; Burman I; Pickens J; Fox N; Schanberg S; Kuhn C Massae therapy reduces anxiety and enhances EEG pattern of alertness and math computations. Int J Neurosci, 86:3-4,197-205,1996

144.Prange AJ.Jr.,Wilson IC, Lara PP., Alltop LB., Breese GR.: Effects of thyrotropine releasing hormones in depression,Lancet, 2: 999-1002,11,1972.

145. Fink M., Shapiro D.,Hickman C, Itil TM.: Quantitate analysis of the electroencephaogram by digital computer methods. 111. Applications to psychopharmacoolgy,in Kline NS., and Laska E., (eds) Computers and Electronic Devices in Psychiatry, Grune & Stratton, New York, l968.

146. Abuzzahab F.S.; The antidepressant properties cyclozacine AJRC.,1:9-l5,l970

147.Fink M., Simeon J., Itil TM., Freedman AM.: Clinical antideprassant activity of cyclazosinea narcotic antagonist,Clin,Pharmacol. Ther., 11:41-48,I97O.

148. Wiegand M; Schreiber W; Lauer C; Berger M The action of clenbuterol on sleep and symptomatology in depressives. Pharmacopsychiatry, 24:3, 89-92, 1991.

149. Steiger A; Guldner J; Colla-Muller M; Friess E; Sonntag A; Schier T Growth hormone- releasing hormone (GHRH)-induced effects on sleep EEG and nocturnal secretion of growth hormone, cortisol and ACTH in patients with major depression. J Psychiatr Res, 28:3, 225-38, 1994.

150.Lauer CJ; Wiegand M; Krieg JC All-night electroencephalographic sleep and cranial computed tomography in depression. A study of unipolar and bipolar patients. Eur Arch Psychiatry Clin Neurosci, 242:2-3, 59-68,1992

151. Steiger A; von Bardeleben U; Wiedemann K; Holsboer F Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission. J Psychiatr Res, 25:4,169-77,1991

152. Lauer CJ; Riemann D; Wiegand M; Berger M From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatry, 29:10, 979-93, 1991

153. Koyama T; Yamashita I Biological markers of depression: WHO multi-center studies and future perspective. Prog Neuropsychopharmacol Biol Psychiatry, 16:6, 791-6, 1992

154.Mendlewicz J; Kerkhofs M Sleep electroencephalography in depressive illness. A collaborative study by the World Health Organization. Br J Psychiatry, 159:, 505-9, 1991

155. Thase ME; Reynolds CF 3d; Frank E; Jennings JR; Garamoni GL; Yeager AL; Kupfer DJ Early return to REM sleep after nocturnal awakening in depression. Biol Psychiatry, 31:2,171-6, 1992

156. Schittecatte M; Garcia-Valentin J; Charles G; Machowski R; Pena-Othaitz MJ; Mendle­wicz J; Wilmotte J Efficacy of the clonidine REM suppression test (CREST)' to separate patients with major depression from controls; a comparison with three currently proposed biological markers of depression. J Affect Disord, 33:3,151-7,1995

157. Dahl RE; Ryan ND; Perel J; Birmaher B; al-Shabbout M; Nelson B; Puig-Antich J Cholinergic REM induction test with arecoline in depressed children. Psychiatry Res, 51:3,269-82, 1994

158. Armitage R; Hoffmann R; Fitch T; Morel C; Bonato R A comparison of period ampli­tude and power spectral analysis of sleep EEG in normal adults and depressed outpatients. Psychiatry Res, 56:3, 245-56,1995

159. Roschke J; Fell J; Beckmann P Nonlinear analysis of sleep EEG in depression: calculation of the largest lyapunov exponent. Eur Arch Psychiatry Clin Neurosci, 245:1,27-35,1995 160. Roschke J; Prentice-Cuntz T; Wagner P; Mann K; Frank C Amplitude frequency characteristics of evoked potentials during sleep: an analysis of the brain's transfer properties in depression. Biol Psychiatry, 40:8, 736-43,1996

161. Armitage R; Roffwarg HP; Rush AJ Digital period analysis of EEG in depression: periodicity, coherence, and interhemispheric relationships during sleep. Prog Neuropsychopharmacol Biol Psychiatry, 17:3,363-72,1993

162. Armitage R; Roffwarg HP; Rush AJ; Calhoun JS; Purdy DG; Giles DE Digital period analysis of sleep EEG in depression. Biol Psychiatry, 31:1, 52-68,1992

163. Gruzelier J; Burgess A; Baldeweg T; Riccio M; Hawkins D; Stygall J; Catt S; Irving G; Catalan J Prospective asociations between lateralised brain function and immune status in HIV infection: analysis of EEG, cognition and mood over 30 months. Int J Psychophysiol, 23:3, 215-24,1996

164. Biondi M; Parise P; Venturi P; Riccio L; Brunetti G; Pancheri P Frontal hemisphere lateralization and depressive personality traits. Percept Mot Skills, 77:3 Pt 1,1035-42, 1993

165. Pulvermuller F; Eulitz C; Pantev C; Mohr B; Feige B; Lutzenberger W; Elbert T; Birbaumer N High-frequency cortical responses reflect lexical processing: an MEG study. Electroencephalogr Clin Neurophysiol, 98:1, 76-85,1996

166. Henriques JB; Davidson RJ Left frontal hypoactivation in depression. J Abnorm Psychol, 100:4, 535-45, 1991

167. Tomarken AJ; Davidson RJ Frontal brain activation in repressors and nonrepressors. J Abnorm Psychol, 103:2, 339-49, 1994

168.Saletu B; Brandstatter N; Metka M; Stamenkovic M; Anderer P; Semlitsch HV; Heytmanek G; Huber J; Griinberger J; Linzmayer; L; Kurz C; Decker K; Binder G;
Knogler W; Koll B Hormonal, syndromal and EEG mapping studies in menopausal
syndrome patients with and without depression as compared with controls. Maturitas, '3:1,91-105,1996

169.Saletu B; Brandstatter N; Metka M; Stamenkovic M; Anderer P; Semlitsch HV; Heytma-G; Huber J; Grunberger J; Linzmayer; L; et al Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermaloest-radiol therapy in menopausal depression. Psychopharmacology (Berl), 122:4, 321-9,1995

170. Shagass C; Roemer RA Evoked potential topography in major depression. II. Comparisons between subgroups. Int J Psychophysiol, 13:3, 255-61,1992

171. Victoroff Jl; Benson F;GraftonST; Engel J Jr; MazziottaJC Depression in complex par­tial seizures. Electroencephalography and cerebral metabolic correlates. Arch Neurol, 51:2,155-63, 1994

172. Mendez MF; Taylor JL; Doss RC; Salguero P Depression in secondary epilepsy: relation to lesion laterality. J Neurol Neurosurg Psychiatry, 57:2, 232-3,1994

173. Mendez MF; Engebrit B; Doss R; Grau R The relationship of epileptic auras and psychological attributes. J Neuropsychiatry Clin Neurosci, 8:3, 287-92,1996

174. Kurthen M; Linke DB; Reuter BM; Hufnagel A; Elger CE Severe negative emotional reactions in intracarotid sodium amytal procedures: further evidence for hemispheric asymmetries? Cortex, 27:2, 333-7,1991

175. Zachariae R; Bjerring P; Arendt-Nielsen L; Nielsen T; Gotliebsen K The effect of hypnotically induced emotional states on brain potentials evoked by painful argon laser stimulation [see comments] Clin J Pain, 7:2, 130-8,1991

176.Nandrino JL; Pezard L; Martinerie J; el Massioui F; Renault B; Jouvent R; Allilaire JF; Widlocher DDecrease of complexity in EEG as a symptom of depression. Neuroreport, 5:4,528-30,1994

177.Strik WK; Dierks T; Becker T; Lehmann D Larger topographical variance and decreased duration of brain electric microstates in depression. J Neural Transm Gen Sect, 99:1-3, 213-22, 1995

178. Burkhart MA; Thomas DG Event-related potential measures of attention in moderately depressed subjects. Electroencephalogr Clin Neurophysiol, 88:1, 42-50,1993

179. Knott VJ; Lapierre YD; de Lugt D; Griffiths L; Bakish D; Browne M; Horn E Preparatory brain potentials in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry, 15:2, 257-62,1991

180. Schneider F; Heimann H; Mattes R; Lutzenberger W; Birbaumer N Self-regulation of slow cortical potentials in psychiatric patients: depression. Biofeedback Self Regul, 17:3,203-14,1992

181.Schlegel S; Nieber D; Herrmann C; Bakauski E Latencies of the P300 component of the auditory event-related potential in depression are related to the Bech-Rafaelsen Melancholia Scale but not to the Hamilton Rating Scale for Depression. Acta Psychiatr Scand, 83:6, 438-40,1991.

182.Schneider LS Psychobiologic features of geriatric affective disorder. Clin Geriatr Med, S 1992 May, 8:2,253-65

183. Lemere R: Cortical energy production in the psychoses. Psychosom.Med.3, 152-156,1941.

184.Davis PA.: Electroencephalograms of manic-depressive patients. Am. J. Psychiatry 98,430-433,1941.

185. Davis PA.: A comparative study of the EEGs of schizophrenic and manic;depressive patients.Am.J.Psychiatry 99, 210-217,1942.

186. Greenblatt M., Healy MM., Jones GA.: Age and electroencephalographic abnormality in neuropschiatric patients: A study of 1953 cases. Am. J. Psychiatry 101,82-90 1944.

187. Hurst LA., Mundy-Castle AC, Beerstecher DM.: The electroencephalogram in manic-depressive psychosis. J. Ment. Sci. 100, 220-240,1954.

188. Harding GFA., Jeavons PM., Jenner FA., Drummond P., Sheridan M., Howels GW .: The electroencephalogram in three cases of periodic psychosis. Electroencephalogy. Clin Neurophysiol. 21, 20-37,1966.

189. Lieber AL., Newbury ND.: Diagnosis and subtyping of depressive disorders by quantitative electroencephalography: III. Discriminating unipolar from bipolar
depression. Hillside J. Clin. Psychiatry 10(2) p.165-172,1988.

190. Nystrom C, Matousek M., Hallstrom T.: Relationships between EEG and biochemical parameters in major depressive disorder. Acta Psychiatr. Scand 77 (4), p.457-62,1988.

191. Hudson Jl; Lipinski JF; Keck PE Jr; Aizley HG; Lukas SE; Rothschild AJ; Waternaux CM; Kupfer DJ Polysomnographic characteristics of young manic patients. Comparison with unipolar depressed patients and normal control subjects [published erratum appears in Arch Gen Psychiatry 1993 Jan; 50 (1):77] Arch Gen Psychiatry, 49:5, 378-83,1992

192.Kwon JS; Youn T; Jung HY Right hemisphere abnormalities in major depression: quantitative electroencephalographic findings before and after treatment. J Affect Disord, 40:3, 169-73, 1996

193.Finkelstein Y; Vardi J; Hod I Impulsive artistic creativity as a presentation of transient cognitive alterations. Behav Med, 17:2, 91-4,1991

194.Kano K; Nakamura M; Matsuoka T; lida H; Nakajima T The topographical features of EEGs in patients with affective disorders. Electroencephalogr Clin Neurophysiol, 83:2, 124-9,1992

195. Gyulai L; Alavi A; Broich K; Reilley J; Ball WB; Whybrow PCI-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: a clinical study. Biol Psychiatry, 41:2,152-61,1997

196. Nieber D; Schlegel S Relationships between psychomotor re-tardation and EEG power spectrum in major depression. Neuropsychobiology, 25:1, 20-3,1992

197. Bruder GE; Fong R; Tenke CE; Leite P; Towey JP; Stewart JE; McGrath PJ; Quitkin FM Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic study. Biol Psychiatry, 41:9, 939-48,1997

198.Pierson A; Ragot R; Van Hooff J; Partiot A; Renault B; Jouvent R Heterogeneity of information-processing alterations according to dimensions of depression: an eventrelated potentials study. Biol Psychiatry, 40:2,98-115,1996

199.Pierson A; Partiot A; Jouvent R; Bungener C; Martinerie J; Renault B; Widlocher D Loss of control of pre-motor activation in anxious agitated and impulsive depressives. A clinical and ERP study. Prog Neuropsychopharmacol Biol Psychiatry, 18:6,1037-50,1994

200. Knott VJ; Lapierre YD Temporal segmentation of response speed in depression: neuro-electrophysiological approaches. Prog Neuropsychopharmacol Biol Psychiatry, 15:2,249-55,1991

201. Bruder GE; Towey JP; Stewart JW; Friedman D; Tenke C; Ouitkin FM Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P3 latency. Biol Psychiatry, 30:3, 233-46,1991

202. Santosh PJ; Malhotra S; Raghunathan M; Mehra YN A study of P300 in melancholic depression—correlation with psychotic features. Biol Psychiatry, 35:7, 474-9,1994

203. Santosh PJ; Malhotra S; Raghunathan M; Mehra YN A study of P300 in melancholic depression—correlation with psychotic features. Biol Psychiatry, 35:7,474-9,1994

204. Arriaga F; Cavaglia F; Matos-Pires A; Lara E; Paiva T EEG sleep characteristics in dysthymiaand major depressive disorder. Neuropsychobiology, 32:3,128-31,1995

205. Akiskal HS Dysthymia: clinical and external validity, Acta Psychiatr Scand Suppl, 383:, 19-23,1994

206. Defrance JF; Ginsberg LD; Rosenberg BA; Sharma JC Topographical analysis of adolescent affective disorders. Int J Neurosci, 86:1-2,119-41,1996

207.Yee CM; Deldin PJ; Miller GA Early stimulus processing in dysthymia and anhedonia. J Abnorm Psychol, 101:2, 230-3,1992

208. Giese-Davis JE; Miller GA; Knight RA Memory template comparison processes in anhedonia and dysthymia. Psychophysiology,30:6,646-56,1993

209. Allen JJ; lacono WG; Depue RA; Arbisi P Regional electroencephalographic asymmetries in bipolar seasonal affective disorder before and after exposure to bright light. Biol Psychiatry, 33:8-9, 642-6,1993

210. Itil TM.: elektroencephalographische studien bei endogenen psychosen und deren Behandlung mit Psychotropen Medi-kamenten unter besonderer Berucksichtigung des Pentothal-elektroencephalogramms. Istanbul Ahmet Said Matbaasi,l964.

211. Brezinova V., Novorna E., Plzak M., Soucek K., Zaviral J.: A contribution to the longitudinal study of manic depressive psychosis. Electroencephalogr. Clin Neurophysiol 20, 284, 1966.

212. Volavka J., Grof P., Mrklas L: EEG prequency analysis in periodic endogenous depressions. Psychiatr. Neural. (Basel) 153,384-390,1967.

213. Fehlow P.: EEG- Befunde bei Psychosen mit besonderer Berucksichtigung des depressiven Syndromes.Psychiart. Neurol. Med. Psychol. (Leip). 26,409-415.1974.

214. Itil TM:, Saletu B.,Davis S.: EEG findings in chronic schizophrenics based on digital computer period analysis and analog power spectra .Biol.Psychiatry 5,1-13,1972.

215. Itil TM., Bhattachyaryya A.,Polvan N.,Huque M.,Menon GN.: Fluvoxime (DU-23.000), a new antidepressant. Quantitative pharmaco-electroencephalography and pilot clinical trials. Progress in Neuro- Psychopharmacoiogy,Vol. 1, p.. 309-322.. Oxford/New York:Pergamon Press,l977.

216. Roschke J; Fell J Spectral analysis of P300 generation in depression and schizophrenia. Neuropsychobiology, 35:2,108-14,1997

217. Sandman CA; Vigor-Zierk CS; Isenhart R; Wu J; Zetin M Cardiovascular phase relationships to the cortical event-related potential of schizophrenic, depressed, and normal subjects. Biol Psychiatry, 32:9, 778-89,1992

218. Ebert D; Feistel H; Barocka A; Kaschka W; Mokrusch T A test-retest study of cerebral blood flow during somatosen-sory stimulation in depressed patients with schizophrenia and major depression. Eur Arch Psychiatry Clin Neurosci, 242:4,250-4,1993

219. Armitage R Microarchitectural findings in sleep EEG in depression: diagnostic implications [see comments] Biol Psychiatry, 37:2,72-84,1995

220. Roschke J; Mann K; Fell J Nonlinear EEG dynamics during sleep in depression and schizophrenia. Int J Neurosci, 75:3-4, 271-84,1994

221. Arikan MK.: 1997, Demans'ta Elektrofizyolojik Bulgular, (Baskida), 1998

222. O'Brien JT, Desmond P, Ames D, Schweitzer I, Tuckwell V, Tress B: The Differentiation of Depression from Dementia by Temporal Lobe Magnetic Resonance Imaging. Psychological Medicine, 24(3):633-40,1994

223. Vida S, Des Rosiers P, Carrier L, Gauthier S: Deperssion in Alzheimer's Disease: Receiver Operating Characteristic Analysis of The Cornell Scale For Deperssion in Dementia and The Hamilton Depression Scale. Journal of Geriatric Psychiatry & Neurology, 7(3}:159-62,1994

224. John ER; Prichep LS; Fridman J; Easton P Neurometrics: computer-assisted differential diagnosis of brain disfunctions.. Science, 239:4836,162-9,1988

225. Jordan SE; Nowacki R; Nuwer M. Computerized electroencephalography in the evaluation of early dementia. Brain Topogr, 1:4,271-82,1989

226. Reynolds CF 3d; Kupfer DJ; Houck PR; Hoch CC; Stack JA; Berman SR; Zimmer B Reliable discrimination of elderly depressed and demented patients by electroencephalographic sleep data.. Arch Gen Psychiatry, 45:3, 258-64,1988

227. Reynolds CF 3d; Kupfer DJ; Hoch CC; Houck PR; Stack JA; Berman SR; Campbell PI; Zimmer B. Sleep deprivation as a probe in the elderly. Arch Gen Psychiatry, 44:11,982-90,1987

228. Buysse DJ; Reynolds CF 3d; Kupfer DJ; Houck PR; Hoch CC; Stack JA; Berman SR. Electroencephalographic sleep in depressive pseudodementia. Arch Gen Psychiatry, 45:6, 568-75,1988

229. Vitiello MV; Bokan JA; Kukull WA; Muniz RL; Smallwood RG; Prinz PN.Rapid eye movement sleep measures of Alzheimer's-type dementia patients and optimally healthy aged individuals. Biol Psychiatry, 19:5,721-34,1984

230. Reynolds CF 3d; Kupfer DJ; Taska LS; Hoch CC; Sewitch DE; Restifo K; Spiker DG; Zimmer B; Marin RS; Nelson J;Sleep apnea in Alzheimer's dementia: correlation with mental deterioration. J Clin Psycrratry, 46:7, 257-61,1985

231. Hoch CC; Reynolds CF 3d; Kupfer DJ; Houck PR; Berman SR; Stack JA Sleep-disordered breathing in normal and pathologic aging.. J Clin Psychiatry, 47:10,499-503,1986

232.Pozzi D; Golimstock A; Migliorelli R; TesUn A; Garcia H; Starkstein S Quantified electroencephalographic correlates of depression in Alzheimer's disease. Biol Psych iatry,34:6, 386-91,1993

233. Kostic VS; Susie V; Przedborski S; Sternic N Sleep EEG in depressed and nondepressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci, 3:2,176-9,1991

234. Shipley JE; Schteingart DE; Tandon R; Starkman MN Sleep architecture and sleep apnea in patients with Cushing's disease. Sleep, 15:6,514-8,1992

235. Gil R; Zai L; Neau JP; Jonveaux T; Agbo C; Rosolacci T; Burbaud P; Ingrand P Event-related auditory evoked potentials and multiple sclerosis. Electroencephalogr Clin Neurophysiol, 88:3,182-7,1993

236. Brown WS; Marsh JT; Woicott D; Takushi R; Carr CR; Higa J; Nissenson AR Cognitive function, mood and P3 latency: effects of the amelioration of anemia in dialysis patients. Neuropsychologia, 29:1, 35-45,1991

237. Fine EJ; Soria ED Myths about vitamin B12 deficiency. South Med J, 84:12,1475-81,1991

238. Prichep LS; Alper K; Kowalik SC; Rosenthal M Neurometric QEEG studies of crack cocaine dependence and treatment outcome. J Addict Dis, 15:4,39-53,1996

239. Reynolds CF 3d; Hoch CC; Buysse DJ; Houck PR; Schlernitzauer M; Frank E; Mazumdar S; Kupfer DJ Electroencephalographic sleep in spousal bereavement and bereavement-related depression of late life. Biol Psychiatry, 31:1, 69-82,1992

240. Pasternak RE; Reynolds CF 3rd; Houck PR; Schlernitzauer M; Buysse DJ; Hoch CC; Kupfer DJ :"Sleep in bereavement-related depression during and after pharmacotherapy with nortriptyline." J Geriatr Psychiatry Neurol, 7:2,69-73,1994

241. McDermott OD; Prigerson HG; Reynolds CF 3rd; Houck PR; Dew MA; Hall M; Mazumdar S; Buysse DJ; Hoch CC; Kupfer DJ: "Sleep in the wake of complicated grief symptoms: an exploratory study." Biol Psychiatry, 41:6,710-6,1997

242.Dahl RE; Ryan ND; Matty MK; Birmaher B; al-Shabbout M; Williamson DE; Kupfer DJ Sleep onset abnormalities in depressed adolescents. Biol Psychiatry, 39:6,400-10,1996

243.Dahl RE; Ryan ND; Birmaher B; al-Shabbout M; Williamson DE; Neidig M; Nelson B; Puig Antich J Electroencephalographic sleep measures in prepubertal depression. Psychiatry Res, 38:2,201-14,1991

244. Gann H; Riemann D; Hohagen F; Dressing H; Mijller WE; Berger M The sleep structure of patients with anxiety disorders in comparison to that of healthy controls and depressive patients under baseline conditions and after cholinergic stimulation. J Affect Disord26:3,179-89,1992

245. Heyman RA; Brenner RP; Reynolds CF 3d; Houck PR; Ulrich RF Age at initial onset of depression and waking EEG variables in the elderly. Biol Psychiatry, 29:10,994-1000,1991

246. Kalayam B; Alexopoulos GS; Musiek FE; Kakuma T; Toro A; Silbersweig D; Young RC Brainstem evoked response abnormalities in late-life depression with vascular disease. Am J Psychiatry, 154:7, 970-5,1997

247. Delvenne V; Kerkhofs M; Appelboom-Fondu J; Lucas F; Mendlewicz J Sleep polygraphic variables in anorexia nervosa and depression: a comparative study in adolescents. J Affect Disord, 25:3,167-72,1992

248.Hohagen F; Lis S; Krieger S; Winkelmann G; Riemann D; Fritsch-Montero R; Rey E; Aldenhoff J; Berger M Sleep EEG of patients with obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci, 243:5, 273-8,1994

249.LauerCJ; Krieg JC; Garcia-Borreguero D;Ozdaglar A; HolsboerF Panic disorder and major depression: a comparative electroencephalographic sleep study. Psychiatry Res, 44:1, 41-54,1992

250.Stein MB; Enns MW; Kryger MH Sleep in nondepressed patients with panic disorder: II. Polysomnographic assessment of sleep architecture and sleep continuity. J Affect Disord, 28:1,1-6,1993

251.Mellman TA; Nolan B; Hebding J; Kulick-Bell R; Dominguez R A polysomnographic comparison of veterans with combat- related PTSD, depressed men, and non-ill controls. Sleep, 20:1, 46-51,1997

252. Williams RL, Karacan I, Moore CA, Hirshkowitz M. Sleep Disorders, in Kaplan HI, Sadock BJ. Comprehensive Textbook of Psychiatry/VI, 6th edition; pp.1373-1408,1995

253. Vasar V, Appelberg B, Selveratnam J, "The Effect of fluoxetine on sleep; a longitudinal, double-blind polysomnographic study of heaithy volunteers" Int. Clin. Psychopharm. 9, 203-206,1994